256.76
price down icon8.73%   -23.36
after-market Dopo l'orario di chiusura: 280.12 23.36 +9.10%
loading

Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie

pulisher
04:11 AM

Bio-Rad Laboratories stock falls on lowered revenue outlook By Investing.com - Investing.com Canada

04:11 AM
pulisher
01:38 AM

Bio-Rad drops 10.2% as guidance cut and Sartorius valuation hit overshadow Q1 results - Quiver Quantitative

01:38 AM
pulisher
01:11 AM

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU - Benzinga

01:11 AM
pulisher
12:15 PM

Why Bio-Rad Laboratories Is Plunging 10.8%: Wells Fargo Maintains Equal-Weight - AlphaStreet

12:15 PM
pulisher
10:35 AM

Wells Fargo & Company Has Lowered Expectations for Bio-Rad Laboratories (NYSE:BIO) Stock Price - MarketBeat

10:35 AM
pulisher
10:29 AM

Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down Following Weak Earnings - MarketBeat

10:29 AM
pulisher
08:30 AM

Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

08:30 AM
pulisher
07:27 AM

Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption - MSN

07:27 AM
pulisher
05:41 AM

Bio-Rad Laboratories Q1 2026 Earnings Call Transcript - MarketBeat

05:41 AM
pulisher
03:57 AM

Bio-Rad Laboratories Inc (BIO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus

03:57 AM
pulisher
02:09 AM

Bio-Rad Laboratories Q1 Earnings Call Highlights - MarketBeat

02:09 AM
pulisher
01:48 AM

BIO SWOT Analysis: Financial Challenges and Growth Potential Rev - GuruFocus

01:48 AM
pulisher
01:34 AM

Bio-Rad Reports First-Quarter 2026 Financial Results - BioSpace

01:34 AM
pulisher
12:08 PM

Bio-Rad Q1 2026 slides: earnings beat masks currency headwinds By Investing.com - Investing.com Canada

12:08 PM
pulisher
Apr 30, 2026

Bio-Rad's Timing for Revenue Growth Recovery Remains Uncertain - Morningstar

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Laboratories (NYSE:BIO) Announces Earnings Results - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad (BIO) Q1 2026: Non-GAAP EPS $1.89 (miss vs $2.81), Reven - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

MSN Money - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad (BIO) Reports Strong Q1 Revenue Amidst Market Challenges - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Q1 2026 slides: earnings beat masks currency headwinds - Investing.com

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Laboratories (BIO) Lags Q1 Earnings Estimates - Yahoo Finance

Apr 30, 2026
pulisher
Apr 30, 2026

Earnings call transcript: Bio-Rad Q1 2026 beats expectations, stock climbs - Investing.com UK

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Laboratories Reports Q1 2026 Results, Cuts Outlook - TipRanks

Apr 30, 2026
pulisher
Apr 30, 2026

Transcript: Bio-Rad Laboratories Q1 2026 Earnings Conference Call - Benzinga

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Laboratories (NYSE:BIO.B) Posts Earnings Results - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Laboratories (BIO) Releases Q1 2026 Earnings: Revenue Up Slightly, EPS Deeply Negative on Large GAAP Loss - Quiver Quantitative

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad: Q1 Earnings Snapshot - KTVB

Apr 30, 2026
pulisher
Apr 30, 2026

Q1 2026 Bio Rad Laboratories Inc Earnings Call Transcript - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q1 Revenue $592.1M, vs. FactSet Est of $589.9M - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

Liquidity Mapping Around (BIO) Price Events - Stock Traders Daily

Apr 30, 2026
pulisher
Apr 30, 2026

Huge Sartorius loss drives Bio-Rad (NYSE: BIO) Q1 2026 net loss - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad (NYSE: BIO) posts Q1 loss and trims 2026 guidance - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad earnings on deck: Can margin recovery offset academic headwinds? - Investing.com Australia

Apr 30, 2026
pulisher
Apr 30, 2026

Bio-Rad earnings on deck: Can margins recover after rough 2025? - Investing.com Canada

Apr 30, 2026
pulisher
Apr 30, 2026

Food Diagnostics Market to Reach USD 32.8 Billion by 2033 at 9.0% - openPR.com

Apr 30, 2026
pulisher
Apr 29, 2026

Transcriptomics Technologies Market to Reach USD 20.64 Billion - openPR.com

Apr 29, 2026
pulisher
Apr 29, 2026

Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers - News-Medical

Apr 29, 2026
pulisher
Apr 28, 2026

Bio-Rad (NYSE: BIO) CFO nets more shares after RSU vesting and tax withholding - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Bio-Rad (BIO) EVP Courtney Enloe gains shares via RSU vesting, withholds for taxes - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Saudi Arabia In-Vitro Diagnostics (IVD) Market Report - GlobeNewswire

Apr 28, 2026
pulisher
Apr 28, 2026

Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux - Yahoo Finance

Apr 28, 2026
pulisher
Apr 27, 2026

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential - DirectorsTalk Interviews

Apr 27, 2026
pulisher
Apr 27, 2026

Citigroup downgrades Bio-Rad Laboratories (BIO) - MSN

Apr 27, 2026
pulisher
Apr 25, 2026

Bio-Rad Laboratories, Inc. Amends 2017 Incentive Award Plan and Updates Entity Information in April 2026 8-K Filing - Minichart

Apr 25, 2026
pulisher
Apr 24, 2026

Bio-Rad Laboratories (BIO.US) will release its earnings report after the market closes on April 30. - Moomoo

Apr 24, 2026
pulisher
Apr 24, 2026

Bio-Rad Laboratories Stockholders Approve Directors and Governance Items - TipRanks

Apr 24, 2026
pulisher
Apr 24, 2026

Shareholders of Bio-Rad (NYSE: BIO) approve 2017 incentive plan changes - Stock Titan

Apr 24, 2026
pulisher
Apr 24, 2026

Bio-Rad Laboratories, Inc. (BIO) PT Reduced to $300 by Citigroup Amid Process Chromatography Concerns - Yahoo Finance

Apr 24, 2026
pulisher
Apr 23, 2026

Bio-Rad Laboratories Inc (BIO) Shares Fall 6.4% -- What GF Score of 77 Tells Investors - GuruFocus

Apr 23, 2026
pulisher
Apr 23, 2026

Greg K. Hinckley adds Bio-Rad (BIO) shares through RSU vesting and grant - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

Bio-Rad (NYSE: BIO) director exercises 407 RSUs and receives 369-unit grant - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

Bio-Rad (NYSE: BIO) director exercises 407 RSUs and gains 369 new units - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

Bio-Rad (BIO) director Arnold Pinkston gains shares, receives new RSU grant - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

9 Most Undervalued Healthcare Stocks to Buy Now - Insider Monkey

Apr 23, 2026
pulisher
Apr 23, 2026

Electroporation Instruments Market is expected to Hit US$ - openPR.com

Apr 23, 2026
pulisher
Apr 23, 2026

Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday - MarketBeat

Apr 23, 2026
pulisher
Apr 23, 2026

Boston Trust Walden Corp Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat

Apr 23, 2026
pulisher
Apr 22, 2026

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpHere's Why - MarketBeat

Apr 22, 2026
pulisher
Apr 22, 2026

DNA Extraction, Isolation and Purification Market: Key Players - openPR.com

Apr 22, 2026
pulisher
Apr 21, 2026

Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com

Apr 21, 2026
pulisher
Apr 21, 2026

Digital PCR Market Set for Strong Growth to US$ 1.45 Billion - openPR.com

Apr 21, 2026
pulisher
Apr 21, 2026

Cell Identification Technology Market Is Going to Boom Rapidly | - openPR.com

Apr 21, 2026
pulisher
Apr 20, 2026

dPCR Market Will Generate Booming Growth Opportunities to 2031 | - openPR.com

Apr 20, 2026
pulisher
Apr 20, 2026

Research Antibodies Market to Reach USD 2,307.59 Billion by 2033 - openPR.com

Apr 20, 2026
pulisher
Apr 20, 2026

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a Healthcare Giant with a 1.16% Upside Potential - DirectorsTalk Interviews

Apr 20, 2026
pulisher
Apr 19, 2026

Why (BIO) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Apr 19, 2026
pulisher
Apr 19, 2026

Is Bio-Rad Laboratories Stock Worth Watching Right Now - Kalkine Media

Apr 19, 2026
ZBH ZBH
$82.90
price up icon 0.57%
STE STE
$214.49
price down icon 0.86%
$61.35
price up icon 3.17%
PHG PHG
$26.17
price down icon 0.46%
$61.03
price up icon 0.25%
EW EW
$83.99
price up icon 0.69%
Capitalizzazione:     |  Volume (24 ore):